18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis

Mikaela L. McKenney-Drake, Mateen C. Moghbel, Koosha Paydary, Mouhamad Alloosh, Sina Houshmand, Sharon Moe, Ali Salavati, Jeffrey M. Sturek, Paul Territo, Connie Weaver, Thomas J. Werner, Poul Flemming Høilund-Carlsen, Michael Sturek, Abass Alavi

Research output: Contribution to journalArticle

Abstract

The early detection of atherosclerotic disease is vital to the effective prevention and management of life-threatening cardiovascular events such as myocardial infarctions and cerebrovascular accidents. Given the potential for positron emission tomography (PET) to visualize atherosclerosis earlier in the disease process than anatomic imaging modalities such as computed tomography (CT), this application of PET imaging has been the focus of intense scientific inquiry. Although 18F-FDG has historically been the most widely studied PET radiotracer in this domain, there is a growing body of evidence that 18F-NaF holds significant diagnostic and prognostic value as well. In this article, we review the existing literature on the application of 18F-FDG and 18F-NaF as PET probes in atherosclerosis and present the findings of original animal and human studies that have examined how well 18F-NaF uptake correlates with vascular calcification and cardiovascular risk.

LanguageEnglish (US)
Pages1-11
Number of pages11
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
DOIs
StateAccepted/In press - Jul 6 2018

Fingerprint

Molecular Probes
Fluorodeoxyglucose F18
Positron-Emission Tomography
Atherosclerosis
Vascular Calcification
Early Diagnosis
Stroke
Myocardial Infarction

Keywords

  • F-FDG
  • F-NaF
  • Atherosclerosis
  • Calcification
  • Cardiovascular disease quantification
  • Global assessment of cardiac disease

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis. / McKenney-Drake, Mikaela L.; Moghbel, Mateen C.; Paydary, Koosha; Alloosh, Mouhamad; Houshmand, Sina; Moe, Sharon; Salavati, Ali; Sturek, Jeffrey M.; Territo, Paul; Weaver, Connie; Werner, Thomas J.; Høilund-Carlsen, Poul Flemming; Sturek, Michael; Alavi, Abass.

In: European Journal of Nuclear Medicine and Molecular Imaging, 06.07.2018, p. 1-11.

Research output: Contribution to journalArticle

McKenney-Drake, ML, Moghbel, MC, Paydary, K, Alloosh, M, Houshmand, S, Moe, S, Salavati, A, Sturek, JM, Territo, P, Weaver, C, Werner, TJ, Høilund-Carlsen, PF, Sturek, M & Alavi, A 2018, '18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis' European Journal of Nuclear Medicine and Molecular Imaging, pp. 1-11. https://doi.org/10.1007/s00259-018-4078-0
McKenney-Drake, Mikaela L. ; Moghbel, Mateen C. ; Paydary, Koosha ; Alloosh, Mouhamad ; Houshmand, Sina ; Moe, Sharon ; Salavati, Ali ; Sturek, Jeffrey M. ; Territo, Paul ; Weaver, Connie ; Werner, Thomas J. ; Høilund-Carlsen, Poul Flemming ; Sturek, Michael ; Alavi, Abass. / 18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis. In: European Journal of Nuclear Medicine and Molecular Imaging. 2018 ; pp. 1-11.
@article{4af64f678b5b4448b042708cd2857c78,
title = "18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis",
abstract = "The early detection of atherosclerotic disease is vital to the effective prevention and management of life-threatening cardiovascular events such as myocardial infarctions and cerebrovascular accidents. Given the potential for positron emission tomography (PET) to visualize atherosclerosis earlier in the disease process than anatomic imaging modalities such as computed tomography (CT), this application of PET imaging has been the focus of intense scientific inquiry. Although 18F-FDG has historically been the most widely studied PET radiotracer in this domain, there is a growing body of evidence that 18F-NaF holds significant diagnostic and prognostic value as well. In this article, we review the existing literature on the application of 18F-FDG and 18F-NaF as PET probes in atherosclerosis and present the findings of original animal and human studies that have examined how well 18F-NaF uptake correlates with vascular calcification and cardiovascular risk.",
keywords = "F-FDG, F-NaF, Atherosclerosis, Calcification, Cardiovascular disease quantification, Global assessment of cardiac disease",
author = "McKenney-Drake, {Mikaela L.} and Moghbel, {Mateen C.} and Koosha Paydary and Mouhamad Alloosh and Sina Houshmand and Sharon Moe and Ali Salavati and Sturek, {Jeffrey M.} and Paul Territo and Connie Weaver and Werner, {Thomas J.} and H{\o}ilund-Carlsen, {Poul Flemming} and Michael Sturek and Abass Alavi",
year = "2018",
month = "7",
day = "6",
doi = "10.1007/s00259-018-4078-0",
language = "English (US)",
pages = "1--11",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - 18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis

AU - McKenney-Drake, Mikaela L.

AU - Moghbel, Mateen C.

AU - Paydary, Koosha

AU - Alloosh, Mouhamad

AU - Houshmand, Sina

AU - Moe, Sharon

AU - Salavati, Ali

AU - Sturek, Jeffrey M.

AU - Territo, Paul

AU - Weaver, Connie

AU - Werner, Thomas J.

AU - Høilund-Carlsen, Poul Flemming

AU - Sturek, Michael

AU - Alavi, Abass

PY - 2018/7/6

Y1 - 2018/7/6

N2 - The early detection of atherosclerotic disease is vital to the effective prevention and management of life-threatening cardiovascular events such as myocardial infarctions and cerebrovascular accidents. Given the potential for positron emission tomography (PET) to visualize atherosclerosis earlier in the disease process than anatomic imaging modalities such as computed tomography (CT), this application of PET imaging has been the focus of intense scientific inquiry. Although 18F-FDG has historically been the most widely studied PET radiotracer in this domain, there is a growing body of evidence that 18F-NaF holds significant diagnostic and prognostic value as well. In this article, we review the existing literature on the application of 18F-FDG and 18F-NaF as PET probes in atherosclerosis and present the findings of original animal and human studies that have examined how well 18F-NaF uptake correlates with vascular calcification and cardiovascular risk.

AB - The early detection of atherosclerotic disease is vital to the effective prevention and management of life-threatening cardiovascular events such as myocardial infarctions and cerebrovascular accidents. Given the potential for positron emission tomography (PET) to visualize atherosclerosis earlier in the disease process than anatomic imaging modalities such as computed tomography (CT), this application of PET imaging has been the focus of intense scientific inquiry. Although 18F-FDG has historically been the most widely studied PET radiotracer in this domain, there is a growing body of evidence that 18F-NaF holds significant diagnostic and prognostic value as well. In this article, we review the existing literature on the application of 18F-FDG and 18F-NaF as PET probes in atherosclerosis and present the findings of original animal and human studies that have examined how well 18F-NaF uptake correlates with vascular calcification and cardiovascular risk.

KW - F-FDG

KW - F-NaF

KW - Atherosclerosis

KW - Calcification

KW - Cardiovascular disease quantification

KW - Global assessment of cardiac disease

UR - http://www.scopus.com/inward/record.url?scp=85049571676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049571676&partnerID=8YFLogxK

U2 - 10.1007/s00259-018-4078-0

DO - 10.1007/s00259-018-4078-0

M3 - Article

SP - 1

EP - 11

JO - European Journal of Nuclear Medicine and Molecular Imaging

T2 - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

ER -